🇺🇸 FDA
Patent

US 9216213

Adjuvanted rabies vaccine with improved viscosity profile

granted A61KA61K2039/5256A61K2039/542

Quick answer

US patent 9216213 (Adjuvanted rabies vaccine with improved viscosity profile) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of Agriculture
Grant date
Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/5256, A61K2039/542, A61K2039/55583, A61K39/12